Mission Street is a specialist investor, developer and operator for the science and innovation sector. The company’s science and innovation portfolio of over 1 million sq ft (93,000 sq m) extends to Cambridge, Oxford and Bristol. Mission Street have also been active as development managers (for example, on Sycamore House in Stevenage, which featured in the 30 September 2022 edition of Life Sciences Real Estate). We caught up with founder and CEO Artem Korolev in his office in London’s West End.
Developers and investors
Interview with Artem Korolev of Mission Street
4 min read
Table of Contents
More from Life Sciences Real Estate